Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion
Frédéric Baron, Pascale Frère, Georges Fillet, Yves BeguinVolume:
123
Year:
2003
Language:
english
Pages:
3
DOI:
10.1046/j.1365-2141.2003.04556.x
File:
PDF, 127 KB
english, 2003